肿瘤的过继性细胞免疫疗法 |
| |
引用本文: | 尚艺曼,王子兵,马一杰,张勇,高全立.肿瘤的过继性细胞免疫疗法[J].国际肿瘤学杂志,2013,40(2):103-106. |
| |
作者姓名: | 尚艺曼 王子兵 马一杰 张勇 高全立 |
| |
作者单位: | 尚艺曼 (450008,郑州大学附属肿瘤医院河南省肿瘤医院生物治疗科);王子兵 (450008,郑州大学附属肿瘤医院河南省肿瘤医院生物治疗科);马一杰 (450008,郑州大学附属肿瘤医院河南省肿瘤医院生物治疗科);张勇 (450008,郑州大学附属肿瘤医院河南省肿瘤医院生物治疗科); 高全立 (450008,郑州大学附属肿瘤医院河南省肿瘤医院生物治疗科); |
| |
摘 要: |
|
Adoptive cellular immunotherapy for cancer |
| |
Institution: | Department of Biotherapy, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China |
| |
Abstract: | Adoptive cellular immunotherapy (ACI) achieves the elimination and control of tumor by mobilizing the body's immune function. It also has targeted efficacy and mild untoward effects. Cytokine-induced killer cells and tumor-infiltrating lymphocytes have been widely used in clinic and have obtained preliminary efficacy. With the development and clinical application of the specific gene transfer of T cell, it will further increase the efficacy of immunotherapy. At present, improving cell culture technology and cell function and using with other treatment are the key links to improve the efficacy of ACI. |
| |
Keywords: | Neoplasms Immunotherapy Killer cells |
|
| 点击此处可从《国际肿瘤学杂志》浏览原始摘要信息 |
| 点击此处可从《国际肿瘤学杂志》下载免费的PDF全文 |
|